These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1109 related articles for article (PubMed ID: 4047738)
21. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. Natali PG; Imai K; Wilson BS; Bigotti A; Cavaliere R; Pellegrino MA; Ferrone S J Natl Cancer Inst; 1981 Sep; 67(3):591-601. PubMed ID: 6944531 [TBL] [Abstract][Full Text] [Related]
22. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468 [TBL] [Abstract][Full Text] [Related]
23. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829 [TBL] [Abstract][Full Text] [Related]
24. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. Herlyn M; Rodeck U; Mancianti M; Cardillo FM; Lang A; Ross AH; Jambrosic J; Koprowski H Cancer Res; 1987 Jun; 47(12):3057-61. PubMed ID: 3034401 [TBL] [Abstract][Full Text] [Related]
25. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens. Berd D; Herlyn M; Koprowski H; Mastrangelo MJ Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430 [TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333 [TBL] [Abstract][Full Text] [Related]
27. Cell surface antigens of melanocytes and melanoma. Albino AP; Houghton AN Cancer Surv; 1985; 4(1):185-211. PubMed ID: 3842314 [TBL] [Abstract][Full Text] [Related]
28. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen. Bumol TF; Chee DO; Reisfeld RA Hybridoma; 1982; 1(3):283-92. PubMed ID: 6208129 [TBL] [Abstract][Full Text] [Related]
29. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen. Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215 [TBL] [Abstract][Full Text] [Related]
30. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules. Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919 [TBL] [Abstract][Full Text] [Related]
31. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. Herlyn M; Guerry D; Koprowski H J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens. Saxton RE; Mann BD; Morton DL; Burk MW Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138 [TBL] [Abstract][Full Text] [Related]
33. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells. Harper JR; Bumol TF; Reisfeld RA J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423 [TBL] [Abstract][Full Text] [Related]
34. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Bumol TF; Reisfeld RA Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1245-9. PubMed ID: 6175965 [TBL] [Abstract][Full Text] [Related]
35. Detection of malignant melanoma with monoclonal antibodies. Saxton RE; Burke MW; Torbett B; Fairhurst M; Morton DL; Cochran AJ Dis Markers; 1988 Jun; 6(2):97-108. PubMed ID: 3042264 [TBL] [Abstract][Full Text] [Related]
36. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions. Kageshita T; Ishihara T; Campoli M; Ferrone S Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896 [TBL] [Abstract][Full Text] [Related]
37. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies. Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356 [TBL] [Abstract][Full Text] [Related]
38. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches. Morgan AC; Woodhouse C; Bartholemew R; Schroff R Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545 [TBL] [Abstract][Full Text] [Related]
39. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89. Holzmann B; Johnson JP; Kaudewitz P; Riethmüller G J Exp Med; 1985 Feb; 161(2):366-77. PubMed ID: 3973533 [TBL] [Abstract][Full Text] [Related]
40. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]